Poster 12
- Kelley Tangredi
- Jun 7, 2024
- 1 min read
Updated: Jun 27, 2024
Long-term Safety and Efficacy of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild-to-Moderate Atopic Dermatitis: A 52-week, Phase 3, Open-Label Safety Trial
Authors: Eric L. Simpson, Lawrence F. Eichenfield, Kim A. Papp, Seth Forman, Adelaide A. Hebert, Mercedes E. Gonzalez, Melinda Gooderham, H. Chih-ho Hong, Vimal H. Prajapati, Emma Guttman-Yassky, Jonathan I. Silverberg, Melissa S. Seal, David Krupa, Patrick Burnett, Scott Synder, David H. Chu, Robert C. Higham, David R. Berk
Poster 12